参考文献/References:
[1] Barbanti M,Costa G,Zappulla P,et al. Incidence of long-term structural valve dysfunction and bioprosthetic valve failure after transcatheter aortic valve replacement[J]. J Am Heart Assoc,2018,7(15):e008440.
[2] Nishimura RA,Otto CM,Bonow RO,et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines[J]. Circulation,2017,135(25):e1159-e1195.
[3] Ejiofor JI,Yammine M,Harloff MT,et al. Reoperative surgical aortic valve replacement versus transcatheter valve-in-valve replacement for degenerated bioprosthetic aortic valves[J]. Ann Thorac Surg,2016,102(5):1452-1458.
[4] Wenaweser P,Buellesfeld L,Gerckens U,et al. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis:the first valve in valve procedure using the corevalve revalving system[J]. Catheter Cardiovasc Interv,2007,70(5):760-764.
[5] Edelman JJ,Khan JM,Rogers T,et al. Valve-in-valve TAVR:state-of-the-art review[J]. Innovations (Phila),2019,14(4):299-310.
[6] Tuzcu EM,Kapadia SR,Vemulapalli S,et al. Transcatheter aortic valve replacement of failed surgically implanted bioprostheses[J]. J Am Coll Cardiol,2018,72(4):370-382.
[7] Vemulapalli S,Holmes DR,Dai D,et al. Valve hemodynamic deterioration and cardiovascular outcomes in TAVR:a report from the STS/ACC TVT Registry[J]. Am Heart J,2018,195:1-13.
[8] Tam DY,Vo TX,Wijeysundera HC,et al. Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve:a systematic review and meta-analysis[J]. Catheter Cardiovasc Interv,2018,92(7):1404–1411.
[9] Wai Sang SL, DeBruine N, Beute T,et al. Midterm outcomes for valve-in-valve TAVR in the failed freestyle bioprosthesis[J]. Ann Thorac Surg,2020,May 19.S0003-4975(20)30729-3.DOI: 10.1016/j.athoracsur.2020.03.116.?Online ahead of print.
[10] Mahmoud AN,Gad MM,Elgendy IY,et al. Outcomes of valve-in-valve transcatheter aortic valve replacement in patients with failed bioprosthetic aortic valves:systematic review and meta-analysis of observational evidence[J]. EuroIntervention,2020,May 19.EIJ-D-19-00928.DOI:10.4244/EIJ-D-19-00928.?Online ahead of print.
[11] Spaziano M,Mylotte D,Thériault-Lauzier P,et al. Transcatheter aortic valve implantation versus redo surgery for failing surgical aortic bioprostheses:a multicentre propensity score analysis[J]. EuroIntervention,2017,13(10):1149-1156.
[12] Ribeiro HB,Rodés-Cabau J,Blanke P,et al. Incidence,predictors,and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves:insights from the VIVID Registry[J]. Eur Heart J,2018,39(8):687-695.
[13] Dvir D,Webb JG,Bleiziffer S,et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves[J]. JAMA,2014,312(2):162.
[14] Pibarot P,Simonato M,Barbanti M,et al. Impact of pre-existing prosthesis-patient mismatch on survival following aortic valve-in-valve procedures[J]. JACC Cardiovasc Interv,2018,11(2):133-141.
[15] Jose J,Sulimov DS,El-Mawardy M,et al. Clinical bioprosthetic heart valve thrombosis after transcatheter aortic?valve replacement:incidence, characteristics,and treatment outcomes[J]. JACC Cardiovasc Interv,2017,10(7):686-697.
[16] Vahidkhah K,Javani S,Abbasi M,et al. Blood stasis on transcatheter valve leaflets and implications for valve-in-valve leaflet thrombosis[J]. Ann Thorac Surg,2017,104(3):751-759.
[17] Abdel-Wahab M,Simonato M,Latib A,et al. Clinical valve thrombosis after transcatheter aortic valve-in-valve implantation[J]. Circ Cardiovasc Interv,2018,11(11):e006730.
[18] Bernardi FLM,Dvir D,Rodes-Cabau J,et al. Valve-in-valve challenges:how to avoid coronary obstruction[J]. Front Cardiovasc Med,2019,6:120.
[19] Ribeiro HB,Nombela-Franco L,Allende R,et al. Coronary obstruction following transcatheter aortic valve implantation for degenerative bioprosthetic surgical valves:a systematic literature review[J]. Rev Bras Cardiol Invasiva Engl Ed,2013,21(4):311-318.
[20] Ribeiro HB,Webb JG,Makkar RR,et al. Predictive factors,management,and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation:insights from a large multicenter registry[J]. J Am Coll Cardiol,2013,62(17):1552-1562.
[21] Maggio S,Gambaro A,Scarsini R,et al. Preventive left main and right coronary artery stenting to avoid coronary ostia occlusion in high-risk stentless valve-in-valve transcatheter aortic valve implantation[J]. Interact Cardiovasc Thorac Surg,2017,25(1):147-149.
[22]Edelman JJ,Khan JM,Rogers T,et al. Valve-in-valve TAVR:state-of-the-art review[J]. Innovations,2019,14(4):299-310.
[23] Khan JM,Dvir D,Greenbaum AB,et al. Transcatheter laceration of aortic leaflets to prevent coronary?obstruction?during transcatheter aortic?valve replacement:concept to first-in-human[J]. JACC Cardiovasc Interv,2018,11(7):677-689.
[24] Jabbour RJ,Tanaka A,Finkelstein A,et al. Delayed coronary obstruction after transcatheter aortic valve replacement[J]. J Am Coll Cardiol,2018,71(14):1513–1524.
[25] Yaakobovich H,Plitman Mayo R,Zaretsky U,et al. Numerical models of valve-in-valve implantation:effect of intentional leaflet laceration on the anchorage[J]. Biomech Model Mechanobiol,2020,19(2):415-426.
[26] Herrmann HC,Daneshvar SA,Fonarow GC,et al. Prosthesis–patient mismatch in?patients?undergoing transcatheter?aortic?valve replacement:from the STS/ACC TVT Registry[J]. J Am Coll Cardiol,2018,72(22):2701-2711.
[27] Deeb GM,Reardon MJ,Chetcuti S,et al. 3-Year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement[J]. J Am Coll Cardiol,2016,67(22):2565-2574.
[28] Flameng W,Herregods MC,Vercalsteren M,et al. Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves[J]. Circulation,2010,121(19):2123-2129.
[29] Azadani AN,Reardon M,Simonato M,et al. Effect of transcatheter aortic valve size and position on valve-in-valve hemodynamics:an in vitro study[J]. J Thorac Cardiovasc Surg,2017,153(6):1303-1315.e1.
[30] Zenses AS,Evin MA,Stanová V,et al. Effect of size and position of self-expanding transcatheter valve on haemodynamics following valve-in-valve procedure in small surgical bioprostheses:an in vitro study[J]. EuroIntervention,2018,14(3):e282-e289.
[31] Sathananthan J,Fraser R,Kütting M,et al. Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions[J]. EuroIntervention,2020,15(15):e1335-e1342.
[32] Grubitzsch H,Galloni M,Falk V. Wrinkles,folds and calcifications:reduced durability after transcatheter aortic valve-in-valve replacement[J]. J Thorac Cardiovasc Surg,2017,153(2):266-268.
[33] Allen KB,Chhatriwalla AK,Cohen DJ,et al. Bioprosthetic valve fracture to facilitate transcatheter valve-in-valve implantation[J]. Ann Thorac Surg,2017,104(5):1501-1508.
[34] Chhatriwalla Adnan K,Allen Keith B,Saxon John T,et al. Bioprosthetic valve fracture improves the hemodynamic results of valve-in-valve transcatheter aortic valve replacement[J]. Circ Cardiovasc Interv,2017,10(7):e005216.
[35] Feindel CM. Aortic root enlargement in the adult[J]. Oper Tech Thorac Cardiovasc Surg,2006,11(1):2-15.
[36] Chakravarty T,S?ndergaard L,Friedman J,et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves:an observational study[J]. Lancet,2017,389(10087):2383-2392.
相似文献/References:
[1]王慧,饶莉.经导管主动脉瓣植入术的影像学研究进展[J].心血管病学进展,2015,(5):531.[doi:10.3969/j.issn.1004-3934.2015.05.002]
WANG Hui,RAO Li.Advances in Study of Imaging of Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2015,(1):531.[doi:10.3969/j.issn.1004-3934.2015.05.002]
[2]蒲华霞 彭礼清.多层螺旋CT在经导管主动脉瓣植入术前评估中的研究进展[J].心血管病学进展,2019,(9):1278.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.024]
PU HuaxiaPeng Liqing.Preoperative Evaluation of Transcatheter Aortic Valve Implantation with Multi-detector Computed Tomography[J].Advances in Cardiovascular Diseases,2019,(1):1278.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.024]
[3]董一娜 雷芳芳 宋启煦 王晶 杨艳.经导管主动脉瓣置换术后死亡风险预测模型系统评价[J].心血管病学进展,2022,(1):76.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.020]
DONG Yina,LEI Fangfang,SONG Qixu,et al.Mortality Risk Prediction Models After Transcatheter?span>Aortic Valve Replacement:A Systematic Review[J].Advances in Cardiovascular Diseases,2022,(1):76.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.020]
[4]何佳玲 陈应忠 刘浩然 叶滔 谢轲 徐俊波 刘汉雄 蔡琳.预防性静脉-动脉体外膜肺氧合支持下的经导管主动脉瓣植入术[J].心血管病学进展,2022,(2):113.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.005]
HE JialingCHEN YingzhongLIU HaoranYE TaoXIE KeXU Junbo,LIU HanxiongCAI Lin.Prophylactic Venous-Arterial Extracorporeal Membrane Oxygenation Supported Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2022,(1):113.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.005]
[5]王璐 李耀东.TAVR合并心房颤动抗凝策略的研究进展[J].心血管病学进展,2022,(8):695.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.007]
WANG Lu,LI Yaodong.Anticoagulation Strategy in Patients After TAVR Complicated with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(1):695.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.007]
[6]周浩 兰富霞 徐英.经导管主动脉瓣植入术后发生脑血管事件的研究进展[J].心血管病学进展,2023,(11):965.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.002]
ZHOU Hao,LAN Fuxia,XU Ying.Cerebrovascular Events After Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2023,(1):965.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.002]